| abstract |
The present invention relates to a method of blocking the invasion, tissue infiltration and / or edema formation of normal, neoplastic, inflammatory or immune cells by inhibiting or modulating molecules and proteolytic enzymes, including, but not limited to, , for the treatment of non-neoplastic angioproliferative diseases, inflammatory diseases or autoimmune diseases, which is based on the use of HIV protease inhibitors (HIV-PI). HE |